Pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer and chronic renal failure who are undergoing hemodialysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples